Researchers analyzed 44 Bundibugyo virus genomes and modeled how approved and experimental Ebola antibodies might bind the ...

The Global Multiple Sclerosis Treatment Market was valued at USD 26.76 Billion in 2025 and is projected to expand at a 5.8% ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of innovative medicines for the treatment ...

Global Autoimmune Treatment Market was valued at USD 176.6 Billion in 2025 and is projected to expand at a 6.9% CAGR from ...

Barzolvolimab is a monoclonal antibody that binds to the receptor tyrosine kinase KIT and inhibits its activity. KIT is expressed in mast cells, the primary drivers of the inflammatory response in CSU ...

Lung cancer remains the deadliest malignancy worldwide, and non-small cell lung cancer (NSCLC) accounts for roughly 85 ...

As the election cycle heats up, the debate over Medicare and the implications of single-payer healthcare resurfaces, raising ...

Good results on Teva's lab-made antibody that blocks gluten damage raise hopes that a treatment for celiac disease may ...

This article explores how advances in antibody engineering are moving immunotherapy beyond traditional monoclonal antibodies to bispecific and trispecific formats and logic-gated designs.

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said the first three participants have received their first dose of intranasal ...

Newswise — SEATTLE — Sept. 16, 2026 — An analysis of more than 60,000 respiratory syncytial virus (RSV) sequences from around the world found that viral variants associated with resistance to current ...